Genome Editing


Genome editing with engineered nucleases (GEEN) is emergent type of Genetic Engineering. GEEN is the technology in which DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level. Genome Editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or mega nucleases.


  • Stem cell and cellular therapies
  • Cell therapy: clinical trials

Related Conference of Genome Editing

August 25-25, 2022

7th International Conference on Molecular Medicine and Diagnostics

Singapore City, Singapore
September 19-20, 2022

International Summit on Genomics and Proteomics

Dublin, Ireland
September 19-20, 2022

15th World Congress on Stem Cell Research

Dublin, Ireland
October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Genome Editing Conference Speakers

Recommended Sessions

Related Journals

Are you interested in